NCT01290302 2025-06-12Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs VidazaAmerican Regent, Inc.Phase 1 Completed38 enrolled 14 charts
NCT06475469 2024-06-26Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious RiskCHU de ReimsPhase NA Recruiting75 enrolled